Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-01-07FDA Approved: CIMETIDINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic drug cimetidine by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2014-01-01Clinical Trial Update: Barrett's Esophagus & Gastroesophageal Reflux Disease
The clinical trial update indicates a completed study involving Barrett's Esophagus and gastroesophageal reflux disease.
-
FDA approval · 2013-12-20FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved a supplemental application for the combination product Omeprazole and Sodium Bicarbonate from Oceanside Pharmaceuticals.
-
FDA approval · 2013-12-20FDA Approved: METOCLOPRAMIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a generic metoclopramide hydrochloride tablet under an original application from Heritage Pharmaceuticals (d/b/a Avet Pharmaceu…
-
FDA approval · 2013-12-19FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for omeprazole from Sandoz Inc, authorizing updates to the approved generic product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Laparoscopic Sleeve Gastrectomy and Gastroesophageal Acid Reflux
A completed clinical trial evaluating the impact of laparoscopic sleeve gastrectomy on gastroesophageal reflux in obese patients.
-
FDA approval · 2013-12-12FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PROTONIX I.V. (pantoprazole sodium), adding an intravenous formulation to treat gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes [NA]
A completed study compared proton-pump inhibitor test responses in Chinese patients with gastroesophageal reflux disease according to CYP2C1…
-
FDA label_change · 2013-12-10FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) to update the product labeling. The sponsor is Wy…
-
FDA approval · 2013-12-10FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for pantoprazole sodium (generic) submitted by Lannett Company, Inc., indicating an additional regul…
-
FDA approval · 2013-12-07FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application for Pepcid Complete, a chewable tablet that combines famotidine with calcium carbonate and magnesium…
-
FDA approval · 2013-11-15FDA Approved: ZEGERID OTC — Supplemental Application (Riley Consumer Care LLC)
The FDA approved a supplemental application for ZEGERID OTC (omeprazole and sodium bicarbonate) submitted by Riley Consumer Care LLC.
-
CLINICAL_TRIALS research · 2013-11-13Clinical Trial Update: LINX Reflux Management System Clinical Study Protocol [NA]
This clinical trial protocol update covers the LINX Reflux Management System study for gastroesophageal reflux disease; the trial (NCT007769…
-
FDA approval · 2013-11-08FDA Approved: RABEPRAZOLE SODIUM — Original Application (Lannett Company, Inc.)
FDA approved the original application for rabeprazole sodium from Lannett Company, Inc., enabling a generic version of the proton pump inhib…
-
FDA approval · 2013-11-08FDA Approved: RABEPRAZOLE SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's original application for generic rabeprazole sodium, a proton pump inhibitor indicated for ga…
-
FDA approval · 2013-10-31FDA Approved: OMEPRAZOLE MAGNESIUM — Supplemental Application (Gericare Pharmaceuticals)
The FDA approved a supplemental application for omeprazole magnesium from Gericare Pharmaceuticals, granting approval for a generic product …
-
CLINICAL_TRIALS research · 2013-10-31Clinical Trial Update: LGG for Prevention of Infectious Complications During PPI Treatment in Children [Phase 4]
Phase 4 clinical trial update evaluating the probiotic Lactobacillus rhamnosus GG (LGG) to prevent infectious complications in children on p…
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients [NA]
This completed prospective, double-blind randomized trial evaluated high-dose rabeprazole (Pariet) for the treatment of reflux laryngitis in…
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: Pepsin As A Biomarker For Aspiration
The trial update notes completion of a study evaluating pepsin as a biomarker for aspiration in patients with aspiration and gastroesophagea…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Comparative Anti-Reflux Procedures in Neurologically Impaired Children [NA]
This clinical trial update summarizes a completed study comparing anti-reflux surgical procedures in neurologically impaired children with g…
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: Anthropometric Measures and Severity of Gastroesophageal Reflux Disease
This update reports on a completed clinical trial investigating how anthropometric measures relate to the severity of gastroesophageal reflu…
-
FDA approval · 2013-10-04FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational
This observational study conducted in Korea evaluated the recurrence rate of gastroesophageal reflux disease after proton pump inhibitor tre…
-
FDA label_change · 2013-09-13FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA lists a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen, typically related to lab…
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: Lansoprazole in Preterm Infants With Reflux [Phase 2]
Phase 2 trial evaluating lansoprazole for gastroesophageal reflux disease in preterm infants has completed.